Language selection

Search


Factors delaying the public listing of drugs in Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier, and Mina Tadrous = Facteurs retardant l'inscription dans les listes de médicaments de régimes...: H82-65/2025-PDF

"The time to public listing for new drugs in Canada has been criticized, citing decentralized public payer structure and institutions leading to a prolonged listing process. We aim to identify and analyze key factors contributing to delays in the time-to-listing"--Objective.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.965451&sl=0

Publication information
Department/Agency
  • Canada. Patented Medicine Prices Review Board, issuing body.
TitleFactors delaying the public listing of drugs in Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier, and Mina Tadrous = Facteurs retardant l'inscription dans les listes de médicaments de régimes publics au Canada / Étienne Gaudette, Shirin Rizzardo, Kevin R. Pothier et Mina Tadrous.
Variant title
  • Facteurs retardant l'inscription dans les listes de médicaments de régimes publics au Canada
Publication typeMonograph
LanguageBilingual-[English | French]
FormatDigital text
Electronic document
Parallel description[French]
Note(s)
  • "NPDUIS, National Prescription Drug Utilization Information System."
  • Includes bibliographical references.
  • Text in English and French.
Publishing information
  • [Ottawa] : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, [2025]
Author / Contributor
  • Gaudette, Étienne, 1953- author.
Description1 online resource (1 page) : colour illustrations
Catalogue number
  • H82-65/2025-PDF
Subject terms
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.

Page details